{"raw_mentions": "Here are the extracted sentences:\n\nUsing that information, Bartlett (Ref. 72) produced a transition state analogue (2.21) which proved to be a powerful inhibitor of the enzyme, Ki of 1.5\u00d710<sup>-7</sup> M, binding much more strongly than chorismate (Km 1.5\u00d710<sup>-5</sup> M for the E.coli enzyme).\nThe enzyme chorismate mutase (EC 5.4.99.5), accelerates the conversion of chorismicacid (2.18) into prephenic acid (2.19) by 3\u00d710<sup>6</sup> and appears to work exclusivelyby restriction of the free rotation of bonds in the substrate, thereby achieving intramolecular juxtaposition of the reacting carbons (FIG. 2D8) (Ref. 70)."}
{"final_json": [{"molecule_name": "2.21", "protein_target_name": "enzyme", "binding_metric": "Ki", "value": "1.5\u00d710^-7", "unit": "M", "is_logarithmic": false}, {"molecule_name": "chorismate", "protein_target_name": "E.coli enzyme", "binding_metric": "Km", "value": "1.5\u00d710^-5", "unit": "M", "is_logarithmic": false}, {"molecule_name": "chorismicacid (2.18)", "protein_target_name": "chorismate mutase (EC 5.4.99.5)", "binding_metric": null, "value": "3\u00d710^6", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "It was inhibited selectively by hapten (2.54), with a Ki of 0.06 mM."}
{"final_json": [{"molecule_name": "hapten (2.54)", "protein_target_name": null, "binding_metric": "Ki", "value": "0.06", "unit": "mM", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text provided does not contain specific molecule names, bioactivity metrics with numeric values, and units that are required for extraction. The text appears to be a theoretical background and methodology description for determining association and dissociation constants, without providing specific experimental data or results that include the required components."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The results in Appendix A, tables 1 and 2 show that the monoclonal antibodies had a large range of affinities for the two TSAs (7.2 and 7.4), ranging from 10^5 to 10^11 M^-1.\n* One of the antibodies, CF7, showed no binding to the TSA (7.37) in the BIAcore assay but had an affinity of 5.2\u00d710^6 M^-1 in the ELISA.\n* The ELISA was able to determine the aK for this clone because the inhibitor concentration could be lowered to a concentration at which 0% inhibition occurred, with a kd that couldn't be measured due to slow dissociation within the time course of the assay (ca. 5 min).\n* It was found that re-binding was a minimal component of the affinity constant, contributing <15% of the kd. \n\nNote that some sentences may not have a specific numeric value for the metric, or may not have a unit for that value, but the above sentences meet the criteria as they contain a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."}
{"final_json": [{"molecule_name": "monoclonal antibodies", "protein_target_name": "TSAs", "binding_metric": null, "value": "10^5 to 10^11", "unit": "M^-1", "is_logarithmic": false}, {"molecule_name": "CF7", "protein_target_name": "TSA (7.37)", "binding_metric": "affinity", "value": "5.2\u00d710^6", "unit": "M^-1", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "kd", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "kd", "value": "<15%", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe inhibitor competes with the solid phase antigen (7.37) for the antibody and hence washes the antibody off the sensor chip in an exaggerated dissociation phase, which is antibody dependent, and the concentration of inhibitor that caused 50% of kmax, I50, was measured for each antibody.\nThe lower the I50 for the inhibitor, the higher is the `relative` affinity of the antibody for the inhibitor (FIG. 9C4).\nThe I50 values, determined graphically, were then correlated with catalytic activity as determined in the SRB screen and the linearity of the relationship examined (FIG. 9C5)."}
{"final_json": [{"molecule_name": null, "protein_target_name": "antibody", "binding_metric": "I50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "antibody", "binding_metric": "I50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "I50", "value": null, "unit": null, "is_logarithmic": false}]}
